HLNN.MX - Haleon plc
| Previous Close | 66.02 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 66.02 - 66.02 |
| 52 Week Range | 66.02 - 66.02 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Yahoo Finance UKTrending tickers: GSK | THG | Beazley | Disney
The latest investor updates on stocks that are trending on Friday.
ACCESSWIREHaleon PLC Announces Redemption of US$300,000,000 Outstanding Notes
Haleon plc ("Haleon") (LSE:HLN)(NYSE:HLN) today announced that its wholly-owned subsidiary GSK Consumer Healthcare Capital US LLC (the "Issuer") is exercising its option to redeem the total outstanding aggregate principal amount of its Callable Floating Rate Senior Notes due 2024 (the "Notes") on March 24, 2023 (the "Redemption Date").
Yahoo Finance UKFTSE 100: GSK lifts profit and sales guidance amid strong demand for vaccines
The GSK group posted an 18% rise in sales to £7.8bn over the third quarter.
Yahoo Finance UKFTSE 100 and Wall Street in the red after Powell’s hawkish speech
Jay Powell sounded hawkish on the outlook for rate rises from the central bank.
ReutersPlaintiff in first Zantac lawsuit set for trial drops case
The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants. Tuesday's news came days after shares of GlaxoSmithKline Plc, Sanofi SA, Pfizer Inc and Haleon Plc were hit by mounting investor concern about thousands of lawsuits claiming the drug, which U.S. regulators pulled from the market in 2020, causes cancer. The plaintiff, Joseph Bayer, alleged he developed esophageal cancer from taking over-the-counter Zantac.
CNW GroupAdvil Introduces Advil PLUS Acetaminophen to Canadians, Combining Two Trusted Pain Relievers into One Convenient Tablet
For more than three decades, Canadians have trusted Advil to deliver relief from pain. New Advil PLUS Acetaminophen – from Haleon (formerly GSK Consumer Healthcare), a leader in pain relief – combines ibuprofen and acetaminophen to fight pain in two ways. This is the first product brought to market by Haleon since launching as an independent company focused entirely on consumer healthcare.
Yahoo Finance UKFTSE 100: GSK raises guidance after strong demand for shingles vaccine
The drugs giant reported a 19% rise in total sales, reaching £6.9bn, with quarterly figures beating expectations for £6.3bn.